This post
continues the coverage of the Oxford Intellectual Property Moot, but approaches
the task from a different angle.
The moot
provides an interesting opportunity to revisit the landmark decisions made by
the Court of Justice of the European Union with the benefit of hindsight and
reference to other jurisdictions.
The moot
focuses on a non-existent country called Erewhon. This country has trade mark
legislation very similar to the EU Trade Marks Directive and Regulation.
However, Erewhon is not bound by any decisions of the CJEU. On the contrary,
the judges are willing to consider jurisprudence from other jurisdictions as an
aid to interpretation of Erewhonian law. The only limitations are the TRIPS
Agreement and the Paris Convention.
The moot
problem for this year is available here.
To summarise it, the case involves two producers of the same drug. The first
one (GBD) has been producing and selling the original drug Fordox under a patent. When
the patent monopoly was expiring, GBD tried to protect its drug using trade
mark law – by registering a word mark for the commercial name of the drug and a
shape mark for the packaging. After the patent expired, the rival company
(Ellebee’s) started producing a cheaper, but otherwise identical generic
version of the same drug under the name Bridge-to-Calm. Ellebee’s is trying to market its generic drug as
effectively as possible – by launching an aggressive advertisement comparing
its cheaper generic drug with the original and by copying elements of the
get-up of the original drug (colour of the pills and elements of the
packaging). GBD sued for trade mark infringement and passing off.
The court
has to establish to what extent trade mark law can protect previously patented
substances and what marketing strategies used to promote generic drugs are
permissible.
Ellebee’s published
an aggressive advertisement using the trade name of the original drug which was
registered as a trade mark by GBD. In the advertisement Ellebee’s called the
rival product ‘overpriced’ and stated that GBD is ‘fleecing’ its consumers by
selling identical drug for a much higher price.
Can this
advertisement amount to a trade mark infringement considering that consumers
are not confused as to the origin of the two drugs?
It would be
a straightforward case of double identity infringement (the trade name of the
original drug is used to promote its identical generic version), but for the
issue of trade mark use (use in a trade mark sense). Does this advertisement affect
the functions of the trade mark?
Under the EU
law this would be an infringement, even though there is no confusion as to the
source of the drugs and even if the indication-of-origin function is not
affected. In L’Oreal v Bellure the ECJ held that there are other essential
functions of a trade mark which can be protected under trade mark law. Among those
are advertising, communication and investment functions. Aggressive advertising
can affect these functions and result in liability.
The ECJ
approach to trade mark use, however, was not followed in Singapore. The Singaporean
Trade Marks Act closely resembles the European Directive – the section on
double identity infringement is the same. Despite this fact, the Singaporean
Court of Appeal in City Chain Stores v Louis Vuitton Malletier carefully considered L’Oreal v Bellure and decided not to follow it. In
Singaporean trade mark law there is only one protectable trade mark function – the
indication-of-origin function.
There are
good reasons to reject the ECJ approach to trade mark use. Although the
principles established in L’Oreal v Bellure were developed and explained in a string
of cases including Google France v Louis Vuitton Malletier and Interflora v
Marks & Spencer, there are still pieces missing from the puzzle.
It does not
seem that the list of protectable functions suggested in L’Oreal v Bellure is
exhaustive. The European Court can still introduce new protectable functions. The
second problem lies with the fact that relationship between the
indication-of-origin, advertising, communication and investment functions is far
from being clear. Stating that these functions overlap, but are distinct from
each other does not help much. If the number of the functions and relationship between
them are not clear, competitors cannot be sure if a particular marketing campaign
will result in a trade mark infringement.
For the
purpose of argument, let us try to go further and pose the following question –
‘Should the trade mark use requirement be implied into the double identity
infringement provision in the first place?’
There are
good reasons to say it should not be implied. Recital 11 of the EU Trade Marks
Directive states that in double identity cases protection should be ‘absolute’.
It should be absolute in a sense that if signs are identical, goods are identical
and the use is in the course of trade, this should be the end of discussion. Prima facie infringement is established.
In fact, some support for absolute liability can be found in the comments made
by Sir Robin Jacob. When L’Oreal v Bellure returned to the Court of Appeal from
the ECJ Jacob LJ (as he then was) thoroughly criticised the approach taken by
the European Court and the idea that functions other than the indication-of-origin
function can be protected. At the same time Jacob LJ lamented that the ECJ did
not come to the same result ‘by a clearer direct route’ – saying that it
was simply ‘a case of same mark/same goods’.
Furthermore,
if liability in double identity infringement cases is absolute and there is no
need for trade mark functions to be affected – this approach may be more in
line with the logic of trade mark infringement provisions.
There are
three different types of trade mark infringements – (1) double identity
infringement – when a sign identical to a registered trade mark is used in
relation to identical goods; (2) similarity coupled with confusion – when a
sign similar or identical to a registered trade mark is used for similar or
identical goods and consumers are likely to be confused as to the origin of the
goods; (3) dilution – when the infringing party uses a sign which is similar or
identical to a trade mark with a reputation to gain unfair advantage or if such
use dilutes the distinctive character of the famous trade mark.
According
to the ECJ case law there is an additional element in all trade mark
infringement cases – there must be trade mark use. Essential functions of a
trade mark (indication-of-origin, advertising, communication or investment) have
to be affected.
But if one
is to look closer into the circumstances under which these functions are
affected, he or she can make a curious discovery. The indication-of-origin function
can be affected if there is a likelihood of confusion as to the origin of the
goods (coincides with the ‘similarity coupled with confusion’ infringement).
Advertising, communication or investment functions are usually infringed when the
competitor receives unfair advantage (coincides with the ‘dilution’
infringement).
Consequently,
introduction of the trade mark use requirement can be justified in cases of
similarity coupled with confusion or in dilution infringements. But there is
nothing in the wording of the double identity provision to suggest that trade
mark use can be required there.
If
liability in double identity infringement is absolute and trade mark functions
need not be affected, the distinction between different types of trade mark
infringements becomes much clearer.
This may seem
to be a radical proposal. There are cases in which a trader should be allowed
to use a sign identical to a registered trade mark in relation to identical
goods. For example, the trader should be able to describe the characteristics
or purpose of his or her goods (e.g. to say that his or her razor blade refills
are compatible with a Gillette razor) or when a trade mark is used to compare
his or her goods or services with the goods or services of another trader (e.g.
to say that his or her services are five times cheaper than services of the
competitor). This is precisely the reason why the ECJ introduced the ‘trade
mark use’ requirement in the first place.
However, such
uses can be allowed without relying on mysterious notions of ‘trade mark use’
and ‘essential functions’. It would be much easier and simpler to allow these
uses by providing specific defences which are already present in national legislation
(e.g. descriptive use defence). The whole idea of duplicating these defences, moving
them to the front and clothing them in the guise of trade mark use seems controversial.
To
summarise, the development of the ‘trade mark use’ requirement in the ECJ case
law left many lawyers and judges racking their brains over it. It is a valid
question to ask now – do we really need it?
No comments:
Post a Comment